Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.1.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
C.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.2 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.82 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.132 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
BA.4.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XANEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used